期刊文献+

胰岛素泵和微调注射器治疗儿童1型糖尿病的临床疗效比较分析 被引量:2

Comparative studies on efficacy of insulin pumps and fine-tune syringe in treatment of children type 1 diabetes
下载PDF
导出
摘要 目的比较1型儿童糖尿病患儿应用胰岛素泵和微调注射器治疗的临床疗效。方法将我院收治的1型糖尿病患儿根据治疗方法不同分为胰岛素泵治疗组(n=13),微调注射器治疗组(n=29),以健康无糖尿病的儿童作为对照组(n=50)。治疗3个月后,比较两个治疗组患儿的FBG、2hPBG、HbA1c改变情况、低血糖发生例次、患儿接受程度、家长满意度,比较胰岛素泵和微调注射器对1型糖尿病患儿的综合疗效。结果两组患儿的空腹血糖合格率比较没有差异(P>0.05),餐后2 h血糖和糖化血红蛋白比较,胰岛素泵组优于微调注射器组(P<0.05);治疗期间不良反应发生率比较,胰岛素泵组少于微调注射器组(P<0.05);胰岛素泵组患儿愿意接受治疗的比例高于微调注射器组(P<0.05);家长满意度比较,胰岛素泵组高于微调注射器组(P<0.05)。结论胰岛素泵对于1型糖尿病患儿疗效显著,能够平稳降低血糖,使患儿的血糖水平全天保持平稳状态,且患儿接受能力强,家长使用方便。但胰岛素泵的应用费用相对较高,如果经济条件允许胰岛素泵是治疗1型糖尿病患儿的有效手段。 Objective To explore the treatment effects between insulin pumps and fine-tune syringe in diabetes children. Methods All 42 typeldiabetes mellitus children were divided into two groups. One was insulin pump group which had 13 cases, the other was fine-tune syringe group which had 29 cases. And took 50 healthy children as contral group. After 3 months, compared the curative effect between two groups on FBG and so on. Results There was no different between two groups on FBG(P 〉 0.05). Fine-tune syringe group had a better effect on 2 h PBG and HbAlc(P 〈 0.05). During treatment adverse reaction rates showed that insulin pump group was better than fine-tune syringe group (P 〈 0.05). Parents of the insulin pump group had a better satisfaction. Conclusion Insulin pumps has better curative effect for type 1 diabetes mellitus children. But the cost of insulin pumps is relatively higher. If the economic conditions allowed, the insulin pump will be an effective means of treatment for type 1 diabetes mellitus children.
出处 《中国现代医生》 2012年第28期34-35,38,共3页 China Modern Doctor
关键词 儿童糖尿病 胰岛素泵 微调注射器 Children diabetes Insulin pump Fine-tune syringe
  • 相关文献

参考文献7

  • 1钱荣立.关于糖尿病的新诊断标准与分型[J].中国糖尿病杂志,2000,8(1):5-6. 被引量:2306
  • 2杨锡强,易著文.儿科学[M].第6版.北京:人民卫生出版社,2003.233-236.
  • 3袁申元,杨光燃.低血糖症[J].国外医学(内分泌学分册),2005,25(1):70-72. 被引量:73
  • 4Rabbone I,Bobbio A,Di Gianni V. Intensive insulin therapy in preschool aged diabetic children: from multiple daily injections to con- tinuous subcutaneous insulin infusion through indwelling catheters [J]. Journal of Endocrinological Investigation, 2008,31 ( 3 ) : 193-195.
  • 5Rabbone I,Searamuzza A, Bobbio A. Insulin pump therapy management in very young children with type ldiabetes using continuous subcuta- neous insulin infusion[J]. Diabetes Technology dr Therapeutics ,2009,11 ( 11 ) .. 707-709.
  • 6吴迪,朱逞.胰岛素泵在儿童糖尿病中的应用[J].药品评价,2011,8(11):29-33. 被引量:2
  • 7蒋成霞 单鸣.胰岛素泵的临床应用[J].中华临床荟萃杂志,2004,15(12):209-209.

二级参考文献12

  • 1Fuld K, Conrad B, Buckingham B, et al. Insulin pumps in young children[J]. Diabetes Technol Ther, 2010, 12(1): S67-71.
  • 2Muller-Godeffroy E, Treichel S, Wagner VM, German Working Group for Paediatric Pump Therapy. Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus- a large-scale multicentre pilot study[J]. Diabetic Medicine, 2009, 26:493- 501.
  • 3Sulmont V, Souchon PF, Gouillard-Darnaud C, et al. Metabolic control in children with diabetes mellitus who are younger than 6 years at diagnosis: continuous subcutaneous insulin infusion as a first line treatment[J]? J Pediatr, 2010, 157(1): 103-107.
  • 4Opipari-Arrigan L, Fredericks EM, Burkhart N, et al. Continuous subcutaneous insulin infusion benefits quality of life in preschool age children with type 1 diabetes mellitus[]]. Pediatr Diabetes, 2007, 8(6): 377-383.
  • 5Nabhan ZM, Kreher NC, Greene DM, et al. A randomized prospective study of insulin pump vs.insulin injection therapy in very young children with type 1 diabetes: 12-month glycemic, BMI, and neurocognitive outcomes[J]. Pediatr Diabetes, 2009, 10: 202-208.
  • 6Rabbone I, Bobbio A, Di Gianni V, et al. Intensive insulin therapy in preschool-aged diabetic children: from multiple daily injections to continuous subcutaneous insulin infusion through indwelling catheters[J]. J Endocrinol Invest, 2008, 31(3): 193 -195.
  • 7Rabbone I, Scaramuzza A, Bobbio A, et al. Insulin pump therapy management in very young children with type ldiabetes using continuous subcutaneous insulin infusion[J]. Diabetes Technol Ther, 2009, 11(11): 707-709.
  • 8Weinzimer SA, Ahern JH, Doyle EA, et al. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow up report[J]. Pediatrics, 2004, 114:1601 -1605.
  • 9Berghaeuser MA, Kapellen T, Heidtmann B, et al. Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria[J]. Pediatr Diabetes, 2008, 9: 590-595.
  • 10DiMeglio LA, Pottorff TM, Boyd SR, et al. A randomized, controlled study of insulin pump therapy in diabetic Preschoolers[J]. J Pediatr, 2004, 45: 380-384.

共引文献2466

同被引文献52

  • 1蒋国萍,李荣,王选琴.胰岛素泵治疗1型糖尿病疗效及安全性的观察[J].重庆医学,2007,36(5):452-453. 被引量:29
  • 2Campochiaro PA, Hafiz G, Mir TA, et al. Pro-Permeability Factors A~ter Dexamethasone Implant in Retinal Vein Occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) Study. Am J Ophthalmol. 2015;160(2):313-321.
  • 3Cani CG, Lopes Lda S, Queiroz M, et al. Improvement in medication adherence and self-management of diabetes with a clinical pharmacy program: a randomized controlled trial in patients with type 2 diabetes undergoing insulin therapy at a teaching hospital. Clinics (Sao Paulo). 2015;70(2):102-106.
  • 4Johnston PC, Lin YK, Walsh RM, et al. Factors associated with islet yield and insulin independence after total pancreatectomy and islet cell autotransplantation in patients with chronic pancreatitis utilizing off-site islet isolation: cleveland clinic experience. J Clin Endocrinol Metab. 2015; 100(5):1765-1770.
  • 5. Kong L, Bhatt AR, DemnyAB, et al. Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2015;56(2):956-961.
  • 6McKinlay C J, Cutfield WS, Battin MR, et al. Cardiovascular risk factors in children after repeat doses of antenatal glucocorticoids: an RCT. Pediatrics. 2015;135(2):e405-e415.
  • 7Porcellati F, Lucidi P, Cioli P, et al. Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes. Diabetes Care. 2015;38(3):503-512.
  • 8Desjardins K, Brazeau AS, Strychar I, et al. Association between post-dinner dietary intakes and nocturnal hypoglycemic risk in adult patients with type 1 diabetes. Diabetes Res Clin Pract. 2014;106(3):420-427.
  • 9Sato K, Satoh S, Muraoka T, et al. Evidence of brain atrophy detected on magnetic resonance imaging is associated with failure of acquisition of the ability for insulin self-injection. Endocr J. 2014;61(11):1125-1130.
  • 10Shiramoto M, Eto 1", Irie S, Fukuzaki A, et al. Single-dose new insulin glargine 300 LI/mL provides prolonged, stable giycaemic control in Japanese and European people with type 1 diabetes. Diabetes Obes Metab. 2015;17(3):254-260.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部